ABBV Iron Condor Strategy
ABBV (AbbVie Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
ABBV (AbbVie Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $368.38B, a trailing P/E of 101.64, a beta of 0.31 versus the broader market, a 52-week range of 176.57-244.81, average daily share volume of 6.9M, a public-listing history dating back to 2013, approximately 55K full-time employees. These structural characteristics shape how ABBV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.31 indicates ABBV has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 101.64 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. ABBV pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a iron condor on ABBV?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
Current ABBV snapshot
As of May 15, 2026, spot at $210.80, ATM IV 25.84%, IV rank 43.94%, expected move 7.41%. The iron condor on ABBV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this iron condor structure on ABBV specifically: ABBV IV at 25.84% is mid-range versus its 1-year history, so the credit collected on a ABBV iron condor sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 7.41% (roughly $15.61 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABBV expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABBV should anchor to the underlying notional of $210.80 per share and to the trader's directional view on ABBV stock.
ABBV iron condor setup
The ABBV iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABBV near $210.80, the first option leg uses a $220.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABBV chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABBV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $220.00 | $2.54 |
| Buy 1 | Call | $230.00 | $0.59 |
| Sell 1 | Put | $200.00 | $2.11 |
| Buy 1 | Put | $190.00 | $1.47 |
ABBV iron condor risk and reward
- Net Premium / Debit
- +$258.50
- Max Profit (per contract)
- $258.50
- Max Loss (per contract)
- -$741.50
- Breakeven(s)
- $197.42, $222.59
- Risk / Reward Ratio
- 0.349
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
ABBV iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on ABBV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$741.50 |
| $46.62 | -77.9% | -$741.50 |
| $93.23 | -55.8% | -$741.50 |
| $139.83 | -33.7% | -$741.50 |
| $186.44 | -11.6% | -$741.50 |
| $233.05 | +10.6% | -$741.50 |
| $279.66 | +32.7% | -$741.50 |
| $326.27 | +54.8% | -$741.50 |
| $372.87 | +76.9% | -$741.50 |
| $419.48 | +99.0% | -$741.50 |
When traders use iron condor on ABBV
Iron condors on ABBV are a delta-neutral premium-collection structure that profits if ABBV stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
ABBV thesis for this iron condor
The market-implied 1-standard-deviation range for ABBV extends from approximately $195.19 on the downside to $226.41 on the upside. A ABBV iron condor is a delta-neutral premium-collection structure that pays off when ABBV stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current ABBV IV rank near 43.94% is mid-range against its 1-year distribution, so the IV signal is neutral; the iron condor thesis on ABBV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ABBV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABBV-specific events.
ABBV iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABBV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABBV alongside the broader basket even when ABBV-specific fundamentals are unchanged. Short-premium structures like a iron condor on ABBV carry tail risk when realized volatility exceeds the implied move; review historical ABBV earnings reactions and macro stress periods before sizing. Always rebuild the position from current ABBV chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on ABBV?
- A iron condor on ABBV is the iron condor strategy applied to ABBV (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With ABBV stock trading near $210.80, the strikes shown on this page are snapped to the nearest listed ABBV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ABBV iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the ABBV iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 25.84%), the computed maximum profit is $258.50 per contract and the computed maximum loss is -$741.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ABBV iron condor?
- The breakeven for the ABBV iron condor priced on this page is roughly $197.42 and $222.59 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ABBV market-implied 1-standard-deviation expected move is approximately 7.41%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on ABBV?
- Iron condors on ABBV are a delta-neutral premium-collection structure that profits if ABBV stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current ABBV implied volatility affect this iron condor?
- ABBV ATM IV is at 25.84% with IV rank near 43.94%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.